Westby Keith's Form 4 filing
IVERIC bio, Inc. (ISEE) · filed Apr 5, 2023
- Accession no.
- 0001410939-23-000046
- Filed
- Apr 5, 2023
- Trade date
- Apr 3, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 3 derivative transactions. Open-market sales total $1.07M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Westby KeithCIK 0001696429 | Officer (SVP, Chief Operating Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +13,786 | $1.45 | +$19,989.7 | 53,438 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +6,214 | $2.94 | +$18,269.16 | 59,652 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseAcquired | +20,000 | $4.52 | +$90,400 | 79,652 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −17,470 | $26.35F2 | −$460,334.5 | 62,182 | Direct | |
| Apr 3, 2023 | Common Stock | SSaleDisposed | −22,530 | $26.98F3 | −$607,859.4 | 39,652 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −13,786 | $1.45 | −$19,989.7 | 0 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −6,214 | $2.94 | −$18,269.16 | 140,000 | Direct | |
| Apr 3, 2023 | Common Stock | MOption exerciseDisposed | −20,000 | $4.52 | −$90,400 | 28,786 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $25.66 to $26.65 per share on April 3, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.
- F3
The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $26.66 to $27.00 per share on April 3, 2023. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range.
Referenced by the price of 1 transaction in Table I.